COVID-19 panel recommends DCGI to permit SII to conduct human trials of Oxford vaccine candidate
SII had submitted a revised proposal on Wednesday after the expert panel had asked it to revise its protocol for the trials…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Covid 19 vaccine
Pfizer and BioNTech sign deal with Japan for 120 mn doses of mRNA-based COVID-19 vaccine
The companies have begun a Phase 2b/3 safety and efficacy trial and remain on track to seek regulatory review as early as October…
J&J begins human trials of COVID-19 vaccine
It will test its vaccine candidate in more than 1,000 healthy adults aged 18 to 55 years, as well as adults aged 65 years and…
Policymakers to identify groups of people who will get priority for COVID-19 vaccine
Four major challenges await India once a vaccine is available, i.e. prioritisation and fair distribution to vulnerable groups;…
UK strikes deal with GSK and Sanofi for 60 mn doses of COVID-19 vaccine
The British government said the latest deal helps grow the country’s portfolio of vaccine candidates and adds to previous…
Pfizer-BioNTech to commence late stage study of COVID-19 vaccine candidate
The study is expected to include about 120 sites globally and up to 30,000 participants
Five sites in India ready for Oxford-AstraZeneca COVID-19 vaccine trial: DBT
The vaccine is in its third phase of human trials, Serum Institute of India is partnering Oxford and AstraZeneca to manufacture…
Moderna begins Phase 3 trials of its COVID-19 vaccine candidate
The randomised, placebo-controlled trial is expected to include approximately 30,000 participants in the US
Serum Institute seeks DCGI nod for phase2/3 trials of Oxford’s COVID-19 vaccine
According to the application, it would conduct an observer-blind, randomised controlled study to determine the safety and…
DBT seed funds Gennova Biopharmaceuticals’ novel mRNA-based COVID-19 vaccine candidate
The clinical trials for the vaccine are likely to start before the year ends